Evidence map›Paper›PMID 41613323›Full record

ArticleFrontiers in medicine2025

Development of a machine learning model for hepatic steatosis screening using non-invasive Traditional Chinese Medicine diagnostics and clinical variables: a health checkup study with community screening potential.

Ke Zhu, Lihua Li, Zhihui Zhao, Sheng Zheng, Bing Lin, Wenjun Tang, Weihong Li

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ke Zhu *Department of Traditional Chinese Medicine Orthopedics and Traumatology, The Third Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Lihua Li *Department of Traditional Chinese Medicine, China-Singapore Guangzhou Knowledge City Hospital, Guangzhou, Guangdong, China.
Zhihui ZhaoSchool of Intelligent Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Sheng ZhengSchool of Rehabilitation Medicine, Gannan Medical University, Ganzhou, Jiangxi, China.
Bing LinHealthcare Management Center, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Wenjun TangDepartment of Respiration, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Weihong LiSchool of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Steatotic liver disease (SLD), underpinned by hepatic steatosis, is a global health concern affecting approximately 30% of the population. Current screening methods primarily rely on laboratory tests and lack broad-spectrum applicability. This study aims to develop a predictive model by selecting from non-invasive Traditional Chinese Medicine (TCM) diagnostics, demographic, and anthropometric variables to enhance early detection of hepatic steatosis. Methods: Data from 1,703 local residents undergoing health checkup at the health management center of Affiliated Hospital of Chengdu University of Traditional Chinese Medicine between December 2018 and December 2021 were analyzed. Demographic, anthropometric, and TCM diagnostic data were collected using questionnaires and standardized instruments. Hepatic steatosis was diagnosed via ultrasonography. Predictive models were developed using three parametric and six non-parametric algorithms, evaluated through nested five-fold stratified cross-validation. Performance was evaluated in terms of discrimination, classification metrics at the optimal threshold, calibration, and clinical utility. Results: Anthropometric variables body mass index (BMI), weight, diastolic blood pressure, and TCM diagnostic indicators HSV_H of nose, T5, phlegm-dampness constitution score, RGB_R of mid tongue, Lab_A of lip, T4, H5, and Lab_A of orbit, a total of 11 variables were selected as predictors. Logistic regression (AUC 0.83, 95% CI: 0.809-0.850) and XGBoost (AUC 0.84, 95% CI: 0.818-0.859) achieved the highest AUC among parametric and non-parametric models, respectively. XGBoost showed marginally better performance than logistic regression in AUC and clinical utility. Difference of classification metrics, calibration slops, and calibration intercepts of the two models was not statistically significant. SHAP analysis identified BMI and body weight as the most influential predictors, alongside substantial contributions from TCM features (HSV_H of nose and T5). Conclusion: TCM features combined with anthropometric variables can be used to develop a non-invasive screening model for ultrasound-diagnosed hepatic steatosis. Both the XGBoost and Logistic Regression models demonstrated robust performance, though external validation is needed to confirm generalizability. This non-invasive approach offers a practical tool with potential for hepatic steatosis screening in community settings.

Indexed as

hepatic steatosismachine learningnon-invasive screeningTraditional Chinese MedicineXGBoost

Identifiers

PMID41613323
PMCPMC12847276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.